Terms: = Skin cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
43 results:
1. Two cases of mycosis fungoides with large cell transformation with kmt2a rearrangements.
Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
3. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
Obermayer AN; Chang D; Nobles G; Teng M; Tan AC; Wang X; Chen YA; Eschrich S; Rodriguez PC; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw TI
BMC Bioinformatics; 2023 Jun; 24(1):266. PubMed ID: 37380943
[TBL] [Abstract] [Full Text] [Related]
4. Myeloid sarcoma in a newborn: A rare manifestation of congenital acute myeloid leukemia.
Mullen B; Sabet K; Jacobs S; Calleroz AT; Habeshian KA; Cheng J
Pediatr Dermatol; 2023; 40(4):751-752. PubMed ID: 37029447
[TBL] [Abstract] [Full Text] [Related]
5. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
6. FOXQ1 recruits the mll complex to activate transcription of EMT and promote breast cancer metastasis.
Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
[TBL] [Abstract] [Full Text] [Related]
7. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
8. Synchronous Basal Cell Carcinoma and Squamous Cell Carcinoma of Nasal Vestibule With Novel Unique Variants Identified by Whole-exome Sequencing.
Ghlichloo I; Jin Z; Fan R; Tong C; Starostik P; Chien JR; Lai J
In Vivo; 2022; 36(1):251-257. PubMed ID: 34972722
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract] [Full Text] [Related]
10. Wide-Field (15 × 9 mm) Swept-Source Optical Coherence Tomography Angiography Following Plaque Radiotherapy of Choroidal Melanoma: An Analysis of 105 eyes.
Lim LS; Camp DA; Ancona-Lezama D; Mazloumi M; Patel SP; McLaughlin JW; Ferenczy SR; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(4):326-334. PubMed ID: 32371740
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
Zhou T; Bloomquist MS; Ferguson LS; Reuther J; Marcogliese AN; Elghetany MT; Roy A; Rao PH; Lopez-Terrada DH; Redell MS; Punia JN; Curry CV; Fisher KE
Pediatr Hematol Oncol; 2020 Feb; 37(1):76-89. PubMed ID: 31682773
[TBL] [Abstract] [Full Text] [Related]
12. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
13. Myeloid Sarcoma.
Magdy M; Abdel Karim N; Eldessouki I; Gaber O; Rahouma M; Ghareeb M
Oncol Res Treat; 2019; 42(4):224-229. PubMed ID: 30840960
[TBL] [Abstract] [Full Text] [Related]
14. Neonatal leukaemia.
Roberts I; Fordham NJ; Rao A; Bain BJ
Br J Haematol; 2018 Jul; 182(2):170-184. PubMed ID: 29806701
[TBL] [Abstract] [Full Text] [Related]
15. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis.
Liang ZG; Lin GX; Ye JX; Li Y; Li L; Qu S; Liang X; Zhu XD
Asian Pac J Cancer Prev; 2018 May; 19(5):1397-1404. PubMed ID: 29802706
[TBL] [Abstract] [Full Text] [Related]
16. Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case report.
Szablewski V; Costes V; Bret C; Dereure O; Yosr H; Alame M; Cacheux V
J Cutan Pathol; 2018 Aug; 45(8):610-614. PubMed ID: 29660158
[TBL] [Abstract] [Full Text] [Related]
17. The protective role of DOT1L in UV-induced melanomagenesis.
Zhu B; Chen S; Wang H; Yin C; Han C; Peng C; Liu Z; Wan L; Zhang X; Zhang J; Lian CG; Ma P; Xu ZX; Prince S; Wang T; Gao X; Shi Y; Liu D; Liu M; Wei W; Wei Z; Pan J; Wang Y; Xuan Z; Hess J; Hayward NK; Goding CR; Chen X; Zhou J; Cui R
Nat Commun; 2018 Jan; 9(1):259. PubMed ID: 29343685
[TBL] [Abstract] [Full Text] [Related]
18. kmt2a promotes melanoma cell growth by targeting hTERT signaling pathway.
Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
[TBL] [Abstract] [Full Text] [Related]
19. [Infant acute leukemia].
Brethon B; Cavé H; Fahd M; Baruchel A
Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
[TBL] [Abstract] [Full Text] [Related]
20. Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
Schmitt RJ; Kreidler SM; Glueck DH; Amaria RN; Gonzalez R; Lewis K; Bagrosky BM; Kwak JJ; Koo PJ
Nucl Med Commun; 2016 Feb; 37(2):122-8. PubMed ID: 26440571
[TBL] [Abstract] [Full Text] [Related]
[Next]
